Vassilios Katsares, PhD
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Anastasia Petsa, PhD
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Antigonos Felesakis, B Sc
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Zissis Paparidis, PhD
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Eleni Nikolaidou, B Sc
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Sofia Gargani, B Sc
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Iliana Karvounidou, B Sc
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Karina-Alina Ardelean, B Sc
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Nikolaos Grigoriadis, B Sc
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

John Grigoriadis, B Sc
Biogenea-Cellgenea Ltd, Trade Centre “Plateia,” Thessaloniki, Greece

Keywords: Cell viability, CytoTox-Glo, trypan blue exclusion test, umbilical cord blood

Upon completion of this activity, you will be able to:

• understand a rapid method for the cell viability evaluation. This method is as accurate as the trypan blue exclusion test, but one can evaluate simultaneously 96 samples in half an hour.